Halobetasol Propionate

Specifications

66852-54-8CAS Number

686-247-0EC Number

[(6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoateIUPAC Name

C25H31ClF2O5Chemical Formula

485 g/molMolecular Weight

HALOBETASOL PROPIONATE; 66852-54-8; Ulobetasol propionate; Ultravate; Jemdel; BMY-30056; DTXSID6046636; CGP-14458; CGP-14,458; BRYHALI; 91A0K1TY3Z; DTXCID4026636; 21-Chloro-6alpha,9-difluoro-11beta,17-dihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-propionate; DUOBRII COMPONENT HALOBETASOL PROPIONATE; Pregna-1,4-diene-3,20-dione, 21-chloro-6,9-difluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)-, (6alpha,11beta,16beta)-; LEXETTE; RefChem:58665; 6-fluoroclobetasol 17-propionate; (1R,8S,13S,14R)-14-(2-chloroacetyl)-1,8-difluoro-17-hydroxy-2,13,15-trimethyl-5-oxotetracyclo(8.7.0.0^(2,7).0^(11,15))heptadeca-3,6-dien-14-yl propanoate; 686-247-0; 6 alpha-fluoroclobetasol 17-propionate; Miracorten; Halobetasol (propionate); MFCD00866013; [(6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate; C25H31ClF2O5; UNII-91A0K1TY3Z; Ulobetasol prop; Halobetasol propionate [USAN]; Ultravate (TN); NCGC00167451-01; Halobetasol propionate [USAN:USP]; BMY 30056; halobetasol-propionate; Halobetasol propionate; Halobetasol propionate-d3; SCHEMBL33858; Halobetasol propionate (USP); CHEMBL1200908; HY-B0878R; BDSYKGHYMJNPAB-LICBFIPMSA-N; CHEBI:135782; HALOBETASOL PROPIONATE [MI]; HY-B0878; Halobetasol (propionate) (Standard); Tox21_112455; MSK011033; s4089; HALOBETASOL PROPIONATE [VANDF]; ULOBETASOL PROPIONATE [MART.]; AKOS025310143; ULOBETASOL PROPIONATE [WHO-DD]; CCG-269585; CS-4305; FH23728; FH57683; HALOBETASOL PROPIONATE [USP-RS]; MSK011033-100A; MSK011033-1000A; NCGC00167451-03; NCGC00167451-04; NCGC00373230-02; CAS-66852-54-8; HALOBETASOL PROPIONATE [ORANGE BOOK]; HALOBETASOL PROPIONATE [USP MONOGRAPH]; A12743; BMY-30056;CGP-14458;Ulobetasol propionate; D04409; AB01566925_01; IDP-118 COMPONENT HALOBETASOL PROPIONATE; SR-01000942239; SR-01000942239-1; Halobetasol propionate Solution in Acetonitrile, 1000ug/mL; Halobetasol propionate Solution in Acetonitrile, 100ug/mL; (6?,11?,16?)-21-Chloro-6,9-difluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)pregna-1,4-diene-3,20-dione; (6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate; 21-Chloro-6alpha,9-difluoro-11beta-hydroxy-16beta-methyl-3,20-dioxopregna-1,4-dien-17-yl propanoate; Miracorten; Ulobetasol propionate; Ultravate; Pregna-1,4-diene-3,20-dione, 21-chloro-6,9-difluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)-, (6|A,11|A,16|A)-; (6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate; PREGNA-1,4-DIENE-3,20-DIONE, 21-CHLORO-6,9-DIFLUORO-11-HYDROXY-16-METHYL-17-(1-OXOPROPOXY)-, (6.ALPHA.,11.BETA.,16.BETA.)-Synonyms